UK markets open in 2 hours 25 minutes

Zevra Therapeutics, Inc. (ZVRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8200-0.2100 (-4.17%)
At close: 04:00PM EDT
5.0500 +0.23 (+4.77%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. Estimate-0.42-0.41-1.53-0.43
Low estimate-0.46-0.45-1.8-1.12
High estimate-0.34-0.31-1.110.49
Year ago EPS-0.15-0.4-1.3-1.53
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate4.65M5.75M29.37M92.78M
Low estimate4.14M5.21M22.71M67.85M
High estimate5M6.2M42.9M141.31M
Year ago sales8.47M2.9M27.46M29.37M
Sales growth (year/est)-45.10%98.60%7.00%215.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.34-0.3-0.27-0.48
Actual EPS-0.15-0.4-0.4-0.4
Difference0.19-0.1-0.130.08
Surprise %55.90%-33.30%-48.10%16.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.41-1.53-0.43
7 days ago-0.43-0.42-1.59-0.52
30 days ago-0.43-0.42-1.58-0.5
60 days ago-0.38-0.37-1.27-0.17
90 days ago-0.37-0.23-1.04-0.01
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2222
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesZVRAIndustrySector(s)S&P 500
Current qtr.-180.00%N/AN/AN/A
Next qtr.-2.50%N/AN/AN/A
Current year-17.70%N/AN/AN/A
Next year71.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A